Synlogic, Inc. (SYBX)
SYBX is quoted over the counter, not listed on an exchange. Synlogic, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-13.
Profile
| Field | Value |
|---|---|
| Ticker | SYBX, quoted over the counter |
| SEC CIK | 0001527599 |
| OTC Markets tier | Pink (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Winchester, MA |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $11.6M cash; operating cash flow -$1.0M a quarter. | Report 2026-09-30 |
| Shares outstanding | 12,248,950 (2026-11-03); 11,698,919 a year earlier; 9,189,353 three years earlier. | Cover page 2026-11-03 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | 3 (8-K item 3.01) | 8-K 2026-01-29 |
| Delisting | 25-NSE filed | 25-NSE 2026-05-18 |
| Auditor | KPMG LLP, Boston, Massachusetts, United States | PCAOB Form AP 2026-04-07 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $284 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $0 | -$3.9M | -$1.6M | $11.6M | No debt tags | $0 | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $0 | -$543K | -$922K | $13.2M | No debt tags | $0 | 10-Q 2026-08-11 |
| Q1 2026 2026-03-31 | $0 | $681K | -$563K | $14.1M | No debt tags | $0 | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $0 | $1.5M | -$923K | $14.7M | No debt tags | $0 | 10-K 2026-03-12 |
| Q3 2025 2025-09-30 | $0 | -$2.3M | -$1.4M | $15.6M | No debt tags | $0 | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $0 | -$529K | -$399K | $17.0M | No debt tags | $0 | 10-Q 2026-08-11 |
| Q1 2025 2025-03-31 | $0 | $317K | -$1.6M | $17.3M | No debt tags | $0 | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $0 | -$714K | -$568K | $18.9M | No debt tags | $8K | 10-K 2026-03-12 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-08-08 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-07-29 |
| Latest proxy | DEF 14A | 2025-11-12 |
Source: SEC EDGAR submissions feed, 628 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier